BioSpace News Archive

The latest market analysis report published by Reports and Data, titled ‘Global Diabetic Neuropathy Market – Forecast to 2030,’ thoroughly examines the Diabetic Neuropathy industry to provide essential data & information for the targeted readers. The report consists of quantitative and qualitative research on the market performed by our market experts.

The latest market analysis report published by Reports and Data, titled ‘Global Diffuse Large B-Cell Lymphoma (DLBCL) Treatment Market – Forecast to 2030,’ thoroughly examines the Diffuse Large B-Cell Lymphoma (DLBCL) Treatment industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Helicobacter Pylori Infections Treatment Market – Forecast to 2030,’ thoroughly examines the Helicobacter Pylori Infections Treatment industry to provide essential data & information for the targeted readers.

SkinCure Oncology, the world leader in providing a comprehensive model for the delivery of Image-Guided Superficial Radiotherapy, the most advanced non-surgical technology for the treatment of common skin cancers, announced the availability of the technology in Oregon.

IHEEZO™ Represents the First Approved Use in the U.S. Ophthalmic Market of Chloroprocaine Hydrochloride and the First Branded Ocular Anesthetic Approved for the U.S. Ophthalmic Market in Nearly 14 Years.

REVA Medical, LLC, a leader in bioresorbable polymer technologies for vascular applications, announced that enrollment in the MOTIV pivotal trial has been initiated at clinical centers in both the U.S. and Europe.

Sept. 27, 2022 18:21 UTC Immunis, Inc., a private biotech company generating an innovative treatment for age and disease-related immune decline, announces that its Chairman, Dr. Hans Keirstead, delivered a keynote on behalf of the National Institute of Child Sexual Assault at the UN General Assembly in New York City.

Biofluidica, Inc., and Hamilton Company, announced a co-marketing agreement to bring advanced Liquid Biopsy capabilities to laboratories worldwide.

Avid Bioservices, Inc. today announced that the company will participate in the RBC Global CDMO Conference. Nick Green, president and chief executive officer, will be the featured speaker in a fireside chat at the conference, which will take place October 3-4, 2022.

Medpace Holdings, Inc. announced that it will report its third quarter 2022 financial results after the market close on Monday, October 24, 2022.